Skip to main navigation Skip to search Skip to main content

Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer

  • Jean Philippe P Theurillat
  • , Namrata D. Udeshi
  • , Wesley J. Errington
  • , Tanya Svinkina
  • , Sylvan C. Baca
  • , Marius Pop
  • , Peter J. Wild
  • , Mirjam Blattner
  • , Anna C. Groner
  • , Mark A. Rubin
  • , Holger Moch
  • , Gilbert G. Privé
  • , Steven A. Carr
  • , Levi A. Garraway

Research output: Contribution to journal › Article › peer-review

Abstract

Cancer genome characterization has revealed driver mutations in genes that govern ubiquitylation; however, the mechanisms by which these alterations promote tumorigenesis remain incompletely characterized. Here, we analyzed changes in the ubiquitin landscape induced by prostate cancer-associated mutations of SPOP, an E3 ubiquitin ligase substrate-binding protein. SPOP mutants impaired ubiquitylation of a subset of proteins in a dominant-negative fashion. Of these, DEK and TRIM24 emerged as effector substrates consistently up-regulated by SPOP mutants.We highlight DEK as a SPOP substrate that exhibited decreases in ubiquitylation and proteasomal degradation resulting from heteromeric complexes of wild-type and mutant SPOP protein. DEK stabilization promoted prostate epithelial cell invasion, which implicated DEK as an oncogenic effector. More generally, these results provide a framework to decipher tumorigenic mechanisms linked to dysregulated ubiquitylation.

Original languageEnglish (US)
Pages (from-to)85-89
Number of pages5
JournalScience
Volume346
Issue number6205
DOIs
StatePublished - Oct 3 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer'. Together they form a unique fingerprint.

Cite this